EPALEX
EpaleX is developing a novel inhaled treatment for epilepsy and migraine. The treatment for the first time provides a way for patients with epilepsy to gain control over their seizures. When a seizure warning sign (aura) occurs, the patient will be able to prevent the development of a full-blown seizure through the use of a pocket nebulizer to deliver a powerful antiseizure medication that rapidly enters the brain and stops the seizure. The effect of the drug dissipates within minutes, allowing the patient to resume normal daily activity. The inhaler is also used to stop migraine attacks that are refractory to currently available migraine treatments.
EPALEX
Social Links:
Industry:
Biotechnology Health Care Life Science Pharmaceutical
Founded:
2009-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.epalex.com
Total Employee:
1+
Status:
Active
Contact:
(650) 346-3380
Email Addresses:
[email protected]
Total Funding:
11 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt WordPress Apache Microsoft Exchange Online Office 365 Mail Google Maps
Similar Organizations
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Neurana Pharmaceuticals
Neurana Pharmaceuticals is currently developing a novel treatment for acute muscle spasms.
Current Employees Featured
Founder
Official Site Inspections
http://www.epalex.com Semrush global rank: 6.17 M Semrush visits lastest month: 1.31 K
- Host name: vps67589.inmotionhosting.com
- IP address: 199.223.115.138
- Location: Los Angeles United States
- Latitude: 33.956
- Longitude: -118.3887
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90045
More informations about "Epalex"
Epalex Breakthrough Therapies for Migraine and Epilepsy
EP103 is a mechanistically novel, broad-spectrum antiseizure agent under development by Epalex for people suffering with drug-refractory epilepsy. EP103 may be particularly useful in treating seizure emergencies because the โฆSee details»
Epalex - Crunchbase Company Profile & Funding
EpaleX is developing a novel inhaled treatment for epilepsy and migraine. The treatment for the first time provides a way for patients with epilepsy to gain โฆSee details»
Epalex 2025 Company Profile: Valuation, Funding
Epalex was founded in 2009. Where is Epalex headquartered? Epalex is headquartered in Mountain View, CA. What is the size of Epalex? Epalex has โฆSee details»
Epalex Corporation - LinkedIn
EpaleX is developing a novel inhaled treatment for epilepsy and migraine. The treatment for the first time provides a way for patients with epilepsy to gain control over their seizures. When a ...See details»
Epalex Corporation Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Epalex Corporation of Mountain View, CA. Get the latest business insights from Dun & Bradstreet.See details»
Epalex - VentureRadar
EpaleX is devoted to the development of novel breakthrough treatments to improve the quality of life for people with epilepsy or migraine. The products are designed for self-administration by โฆSee details»
Epalex Corporation Overview | SignalHire Company Profile
Epalex Corporation is a private company that has been in the industry for 15 years. The company currently specializes in the Pharmaceuticals area. ... Organization Website: epalex.com : โฆSee details»
Epalex Corporation in South San Francisco CA - Company Profile
Sep 16, 2013 Epalex Corporation Overview. Epalex Corporation filed as a Statement & Designation By Foreign Corporation in the State of California on Monday, September 16, 2013 โฆSee details»
Epalex Company Profile - Office Locations, Competitors, Revenue โฆ
Epalex is a company devoted to the development of treatments to improve the quality of life for people with migraines and epilepsy. It offers EP-102 and EP-103, treatments for acute โฆSee details»
Epalex - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial โฆSee details»
Epalex - Contacts, Employees, Board Members, Advisors & Alumni
Epalex is developing a novel inhaled treatment for epilepsy and migraine.See details»
Epalex - Org Chart, Teams, Culture & Jobs - The Org
View Epalex's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Epalex - Overview, News & Similar companies | ZoomInfo.com
Who is Epalex. The research programs of EpaleX have been supported by the University of California, Davis; the Epilepsy Therapy Project; the Epilepsy Foundation o f America; and the โฆSee details»
Our Focus โ Epalex Breakthrough Therapies for Migraine and โฆ
The Epalex drug development candidates have a unique mechanism of action that is differentiated from existing therapies. Site Links. Home; Our Medicine; Our Focus; Our People; โฆSee details»
Epalex Corporation - Company Profile & Staff Directory - ContactOut
EpaleX is developing a novel inhaled treatment for epilepsy and migraine. The treatment for the first time provides a way for patients with epilepsy to gain control over their seizures. When a โฆSee details»
Epalex - Products, Competitors, Financials, Employees, โฆ
Epalex is a clinical-stage pharmaceutical company that focuses on developing therapies for migraine and epilepsy. The company offers treatments that feature a unique mechanism of โฆSee details»
Epalex Corp. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Epalex Corp. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Nervous System Diseases, Technology Platform:Small molecule drug ...See details»
Our Medicine โ Epalex Breakthrough Therapies for Migraine and โฆ
EP103 For Epilepsy . Epalex is developing EP103 for the control of seizure disorders resistant to available therapies. EP103 is an oral formulation that can deliver therapeutic levels of an FDA โฆSee details»
Epalex - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. Epalex . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 3. About. Epalex is actively โฆSee details»
Epalex Corp. (Epalex Corp.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่่ฅๆถ_ๆ โฆ
ไบ่งฃEpalex Corp. (Epalex Corp.)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็๏ผ็พ็ ้ขๅ:็ฅ็ป็ณป็ป็พ็ ๏ผๆๆฏๅนณๅฐ:ๅฐๅๅญๅ่ฏ๏ผ่ฏ็ฉ:EP-102 (Epalex)๏ผEP-103 (Epalex)ใSee details»